The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Origin of the U87MG glioma cell line: Good news and bad news
Abstract
The DNA profile of the publicly available and widely used glioma cell line U87MG is quite different from that of the original cell line.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies using the classic U87MG and U251MG glioma cell lines have shown that when grown in serum-containing medium these glioma cells exhibit transcrip-tomic deviation from the original tumour from which they were derived63.”
From How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) · cites this paper as [63]
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345
Pollard, S. M., Yoshikawa, K., Clarke, I. D., Danovi, D., Stricker, S., Russell, R., Bayani, J., Head, R., Lee, M., Bernstein, M., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.014 · Cited by 1,025
LONG TERM CULTURE OF NORMAL AND NEOPLASTIC HUMAN GLIA
Pontén, J., & Macintyre, E. H. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb03502.x · Cited by 721
Absence of HeLa Cell Contamination in 169 Cell Lines Derived From Human Tumors2
Fogh, J., Wright, W. C., & Loveless, J. D. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/58.2.209 · Cited by 663
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520 · cited 1×
“Theproblemof themisidentification of cell lines has beenhighlighted in several reports (11, 12), and a number of scientific journals now want the identity of the samples and cell lines used in their publication to be confirmed.”
BackgroundXie, Y., Bergström, T., Jiang, Y., Johansson, P., Marinescu, V. D., Lindberg, N., Segerman, A., Wicher, G., Niklasson, M., Baskaran, S., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.026 · Cited by 329
Self-citationCell line misidentification: the beginning of the end
American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (2010) · Nature Reviews Cancer · doi:10.1038/nrc2852 · Cited by 266
DNA fingerprinting in forensics: past, present, future
Roewer, L. (2013) · Investigative Genetics · doi:10.1186/2041-2223-4-22 · Cited by 182
Schraer, L., Borum, I., & Sathyan, T. G. (1995) · Cited by 113
Flagged first, then by citations
1 of the 15 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 464
Han, L., Yuan, B., Shimada, R., Hayashi, H., Si, N., Zhao, H., Bian, B., & Takagi, N. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4567 · Cited by 36
Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion
Liu, G., Yan, T., Li, X., Sun, J., Zhang, B., Wang, H., & Zhu, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.6124 · Cited by 35
Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ
Xu, X., Wang, Z., Liu, N., Cheng, Y., Jin, W., Zhang, P., Wang, X., Yang, H., Liu, H., Zhang, Y., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4382 · Cited by 35
Li, J., Song, J., & Guo, F. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3940 · Cited by 35
Intracellular stiffening competes with cortical softening in glioblastoma cells
Alibert, C., Pereira, D., Lardier, N., Etienne‐Manneville, S., Goud, B., Asnacios, A., & Manneville, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2021.120903 · Cited by 36
Шевченко, В. Е., Arnotskaya, N. E., Korneyko, M., Zaytsev, S., Khotimchenko, Y. S., Sharma, H., & Bryukhovetskiy, I. (2019) · Oncology Reports · doi:10.3892/or.2019.7043 · Cited by 34
Mu, P., Liu, K., Lin, Q., Yang, W., Liu, D., Lin, Z., Shao, W., & Ji, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.9800 · Cited by 34
RetractedGADD45A plays a protective role against temozolomide treatment in glioblastoma cells
Wang, H.-H., Chang, T., Lin, W.-C., Wei, K., & Shin, J.-W. (2017) · Scientific Reports · doi:10.1038/s41598-017-06851-3 · Cited by 33
Tissue-derived extracellular vesicles: Research progress from isolation to application
Qin, B., Hu, X., Su, Z., Zeng, X.-B., Ma, H., & Xiong, K. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153604 · Cited by 33
Way, G. P., Allaway, R. J., Bouley, S. J., Fadul, C. E., Sánchez, Y., & Greene, C. S. (2017) · BMC Genomics · doi:10.1186/s12864-017-3519-7 · Cited by 33
Venerable brain-cancer cell line faces identity crisis
Dolgin, E. (2016) · Nature · doi:10.1038/nature.2016.20515 · Cited by 33
Glioblastoma Vasculature: From its Critical Role in Tumor Survival to Relevant in Vitro Modelling
Pacheco, C., Martins, C., Monteiro, J., Baltazar, F., Costa, B. M., & Sarmento, B. F. C. C. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.823412 · Cited by 33
Ivanov, V. N., Wu, J., Wang, T. J. C., & Hei, T. K. (2019) · Oncotarget · doi:10.18632/oncotarget.26582 · Cited by 32
Wang, K., Huang, R., Li, G., Zeng, F., Zhao, Z., Liu, Y., Hu, H., & Jiang, T. (2018) · Oncology Reports · doi:10.3892/or.2018.6611 · Cited by 31
The function of histone methylation and acetylation regulators in GBM pathophysiology
McCornack, C. R., Woodiwiss, T. R., Hardi, A., Yano, H., & Kim, A. H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1144184 · Cited by 33
Kutwin, M., Sawosz, E., Jaworski, S., Wierzbicki, M., Strojny, B., Grodzik, M., & Chwalibóg, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178277 · Cited by 31
Halle, B., Mongelard, K. B. G., & Poulsen, F. R. (2018) · Asian Journal of Neurosurgery · doi:10.4103/ajns.ajns_302_17 · Cited by 31
Umlauf, B. J., Clark, P. A., Lajoie, J. M., Georgieva, J. V., Bremner, S. B., Herrin, B. R., Kuo, J. S., & Shusta, E. V. (2019) · Science Advances · doi:10.1126/sciadv.aau4245 · Cited by 30
A 3D tumor spheroid model for the T98G Glioblastoma cell line phenotypic characterization
Oraiopoulou, M., Tampakaki, M., Tzamali, E., Tamiolakis, T., Makatounakis, V., Vakis, A. F., Zacharakis, G., Sakkalis, V., & Papamatheakis, J. D. (2019) · Tissue and Cell · doi:10.1016/j.tice.2019.05.007 · Cited by 30
Zhu, D., Trinh, P., Li, J., Grant, G., & Yang, F. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37093 · Cited by 30
Inkjet‐Patterned Microdroplets as Individual Microenvironments for Adherent Single Cell Culture
Xie, T., Zhang, Q., Zhang, W., Feng, S., & Lin, J. (2022) · Small · doi:10.1002/smll.202107992 · Cited by 29
Parisi, A., Beltran, C. J., & Furutani, K. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012491 · Cited by 29
Magallón‐Lorenz, M., Terribas, E., Ortega‐Bertran, S., Creus‐Bachiller, E., Fernández, M. A., Requena, G., Rosas, I., Mazuelas, H., Uriarte-Arrazola, I., Negro, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106096 · Cited by 31
Oppermann, H., Ding, Y., Sharma, J., Berndt‐Paetz, M., Meixensberger, J., Gaunitz, F., & Birkemeyer, C. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0131-9 · Cited by 29
Kumar, N., Lal, N., Nemaysh, V., & Luthra, P. M. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103911 · Cited by 29
Biomaterial-based in vitro 3D modeling of glioblastoma multiforme
Ahmed, T. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.01.002 · Cited by 31
Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma
DePalma, T. J., Sivakumar, H., & Skardal, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114067 · Cited by 30
Fedorová, V., Pospíšilová, V., Váňová, T., Černá, K. A., Abaffy, P., Sedmík, J., Raška, J., Vochyánová, S., Matusova, Z., Houserova, J., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13389 · Cited by 30
Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells
Villodre, E. S., Kipper, F. C., Silva, A. O., Lenz, G., & Lopez, P. L. D. C. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0611-6 · Cited by 28
Chen, H.-W., Lin, R. J., Zhang, Z., Wei, Q., Zhong, Z., Huang, J., & Xu, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10235 · Cited by 27
Pettke, A., Tampere, M., Pronk, R., Wallner, O. A., Falk, A., Berglund, U. W., Helleday, T., Mirazimi, A., & Puumalainen, M.-R. (2020) · Viruses · doi:10.3390/v13010037 · Cited by 27
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity
Schniewind, I., Hadiwikarta, W. W., Grajek, J., Poleszczuk, J., Richter, S., Peitzsch, M., Müller, J., Klusa, D., Beyreuther, E., Löck, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110422 · Cited by 27
Morris, E. K., Daignault, S. M., Stehbens, S. J., Genovesi, L. A., & Lagendijk, A. K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1101522 · Cited by 28
Gale, J. R., Hartnett, K. A., Ross, M. M., Rosenberg, P. A., & Aizenman, E. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15961 · Cited by 27
Gao, Y., Zhu, T., Chen, J., Liu, L., & Ouyang, R. (2018) · Oncology Letters · doi:10.3892/ol.2018.8830 · Cited by 27
Graphene oxide down-regulates genes of the oxidative phosphorylation complexes in a glioblastoma
Szmidt, M., Stankiewicz, A. M., Urbańska, K., Jaworski, S., Kutwin, M., Wierzbicki, M., Grodzik, M., Burzyńska, B., Góra, M., Chwalibóg, A., et al. (2019) · BMC Molecular Biology · doi:10.1186/s12867-018-0119-2 · Cited by 27
Emerging Roles of Primary Cilia in Glioma
Sarkisian, M. R., & Semple‐Rowland, S. L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00055 · Cited by 27
Li, S., Chen, S., Li, Y., Sun, W., Li, J., Deng, H., Ding, H., Wang, Z., Zhu, L., Liu, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq5331 · Cited by 27
Research advances and challenges in tissue-derived extracellular vesicles
Zhi, Z., Sun, Q., & Tang, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1036746 · Cited by 26
μMESH-Enabled Sustained Delivery of Molecular and Nanoformulated Drugs for Glioblastoma Treatment
Mascolo, D. D., Guerriero, I., Pesce, C., Spanò, R., Palange, A. L., & Decuzzi, P. (2023) · ACS Nano · doi:10.1021/acsnano.3c01574 · Cited by 26
CRISPR/Cas9 Editing for Gaucher Disease Modelling
Pavan, E., Ormazábal, M., Peruzzo, P., Vaena, E., Rozenfeld, P. A., & Dardis, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093268 · Cited by 27
Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells
Pruteanu, L.-L., Kopanitsa, L., Módos, D., Kletnieks, E., Samarova, E. I., Bender, A., Gomez, L. D., & Bailey, D. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239551 · Cited by 26
Zimmerman, M. A., Wilkison, S. J., Qi, Q., Chen, G., & Li, P. A. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.40159 · Cited by 25
Zhou, J., Kong, Y. S., Vincent, K. M., Dieters‐Castator, D. Z., Bukhari, A. B., Glubrecht, D. D., Liu, R., Quilty, D., Findlay, S. D., Huang, X., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13434 · Cited by 25
Mansur, A. A. P., Mansur, H. S., Carvalho, S. M., & Caires, A. J. (2017) · Contrast Media & Molecular Imaging · doi:10.1155/2017/3896107 · Cited by 25
Nuclear GSK3β induces DNA double-strand break repair by phosphorylating 53BP1 in glioblastoma
Yang, Y., Lei, T., Du, S., Tong, R., Wang, H., Yang, J., Huang, J., Sun, M., Wang, Y., & Dong, Z. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4237 · Cited by 25
Joalland, N., Chauvin, C., Oliver, L., Vallette, F. M., Pecqueur, C., Jarry, U., & Scotet, E. (2018) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000225 · Cited by 25
CADM2 inhibits human glioma proliferation, migration and invasion
Liu, N., Chen, Y., Bai, W., Wang, Z., Wang, X., Johnson, M., Wang, W., Zhang, P., Yang, H. W., Liu, H., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7010 · Cited by 25
3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application
Branco, F., Cunha, J., Mendes, M., Sousa, J., & Vitorino, C. (2025) · Advanced Materials · doi:10.1002/adma.202501994 · Cited by 24
A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models
Jue, T. R., Sena, E. S., Macleod, M. R., McDonald, K. L., & Hirst, T. C. (2018) · Oncotarget · doi:10.18632/oncotarget.24334 · Cited by 24
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
Regmi, M., Wang, Y., Liu, W., Dai, Y., Liu, S., Ma, K., Lin, G., Yang, J., Liu, H., Wu, J., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02973-5 · Cited by 24
Wang, C., Jiang, M., Hou, H., Lin, Q., Yan, Z., & Zhang, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.9355 · Cited by 24
Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis
Xiao, B., Li, J., Fan, Y., Ye, M., Lv, S., Xu, B., Chai, Y., Zhou, Z., Wu, M., & Zhu, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7723 · Cited by 23
Kinase-Modulated Bioluminescent Indicators Enable Noninvasive Imaging of Drug Activity in the Brain
Wu, Y., Walker, J. R., Westberg, M., Lin, N., Monje, M., Kirkland, T. A., Lin, M. Z., & Su, Y. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00074 · Cited by 23
Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma
Шевченко, В. Е., Arnotskaya, N. E., Zaitsev, S., Sharma, A., Sharma, H. S., Bryukhovetskiy, A. S., Pak, O., Khotimchenko, Y. S., & Bryukhovetskiy, I. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.006 · Cited by 22
Rusak, A., Buzalewicz, I., Mrozowska, M., Wiatrak, B., Haczkiewicz-Leśniak, K., Olbromski, M., Kmiecik, A. M., Krzyżak, E., Pietrowska, A., Moskal, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114520 · Cited by 22
Lu, M., Wang, Y., Zhou, S., Xu, J., Li, J., Tao, R., & Zhu, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5494 · Cited by 22
Liu, H.-J., Wang, L., Kang, L., Du, J., Li, S., & Cui, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495274 · Cited by 22
Paiva, A. E., & Borsagli, F. G. L. M. (2020) · Journal of Polymers and the Environment · doi:10.1007/s10924-020-01825-5 · Cited by 22
Human Brain Neuropharmacology: A Platform for Translational Neuroscience
Dragunow, M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.002 · Cited by 23
Yang, B., Li, X., He, L., & Zhu, Y. T. (2018) · Biomedical Reports · doi:10.3892/br.2018.1051 · Cited by 21
Шевченко, В. Е., Arnotskaya, N. E., Pak, O., Sharma, A., Sharma, H. S., Khotimchenko, Y. S., Bryukhovetskiy, A. S., & Bryukhovetskiy, I. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.005 · Cited by 21
Development and optimisation of in vitro sonodynamic therapy for glioblastoma
Keenlyside, A., Marples, T., Gao, Z., Hong, H., Nicely, L. G., Nogales, J., Li, H., Landgraf, L., Solth, A., Melzer, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47562-2 · Cited by 21
Best practices for authenticating cell lines
Nims, R. W., & Reid, Y. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0212-8 · Cited by 21
Modeling Microenvironmental Regulation of Glioblastoma Stem Cells: A Biomaterials Perspective
Heffernan, J. M., & Sirianni, R. W. (2018) · Frontiers in Materials · doi:10.3389/fmats.2018.00007 · Cited by 21
Gao, Y., Zhang, E., Liu, B., Zhou, K., He, S., Feng, L., Wu, G., Cao, M., Wu, H., Cui, Y., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14507 · Cited by 21
Diosmin induces caspase-dependent apoptosis in human glioblastoma cells
SOARES, J. M., de Faria, B. M., Ascari, L. M., Alves‐Leon, S. V., de Souza, J. M., Soares, A. G., Cordeiro, Y., & Romão, L. F. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920191031 · Cited by 21
Kretschmer, M., Kadlubowska, P., Hoffmann, D. E., Schwalbe, B., Auerswald, H., & Schreiber, M. (2020) · Cancers · doi:10.3390/cancers12041000 · Cited by 21
Radiotherapy of high-grade gliomas: dealing with a stalemate
Fròsina, G. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104110 · Cited by 20
Neutrophils traffic in cancer nanodrugs
Osuka, S., & Meir, E. G. V. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.82 · Cited by 20
Facchini, G., Ignarro, R. S., Rodrigues-Silva, E., Vieira, A. S., Lopes‐Cendes, Í., Castilho, R. F., & Rogério, F. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2672-9 · Cited by 20
Cai, X., Yang, Y., Xia, W., Kong, H., Wang, M., Fu, W., Long, M., Hu, Y., & Xu, D. (2018) · Oncology Reports · doi:10.3892/or.2018.6397 · Cited by 20
C1q/ TNF ‐related peptide 8 ( CTRP 8) promotes temozolomide resistance in human glioblastoma
Thanasupawat, T., Głogowska, A., Burg, M., Krcek, J. P., Beiko, J., Pitz, M. W., Zhang, G., Hombach‐Klonisch, S., & Klonisch, T. C. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12349 · Cited by 23
The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models
Fròsina, G., Marubbi, D., Marcello, D., Vecchio, D., & Daga, A. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.04.015 · Cited by 20
CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model.
Han, J.-H., Yoon, J. S., Chang, D., Cho, K. G., Lim, J., Kim, S., & Suh‐Kim, H. (2020) · PubMed Central · doi:10.14348/molcells.2020.0098 · Cited by 20
Cytotoxic effect of boron application on glioblastoma cells
Aydın, H. E., Gündüz, M. K., Kızmazoğlu, C., Kandemir, T., & Arslantaş, A. (2020) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.30316-20.1 · Cited by 20
Fròsina, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168942 · Cited by 20
Jiang, Y., Miao, J., Wang, D., Zhou, J., Liu, B., Jiao, F., Liang, J., Wang, Y., Fan, C., & Zhang, Q. (2018) · Oncology Letters · doi:10.3892/ol.2018.8073 · Cited by 20
Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy
Wilson, K. M., Mathews-Griner, L. A., Williamson, T., Guha, R., Chen, L., Shinn, P., McKnight, C. G., Michael, S., Klumpp-Thomas, C. A., Binder, Z. A., et al. (2018) · SLAS TECHNOLOGY · doi:10.1177/2472630318803749 · Cited by 20
The Tumorgenicity of Glioblastoma Cell Line U87MG Decreased During Serial In Vitro Passage
Zeng, Y., Wang, X., Wang, J., Yi, R., Long, H., Zhou, M., Luo, Q., Zhai, Z., Song, Y., & Qi, S. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0592-7 · Cited by 19
Eichberg, D. G., Slepak, T. I., Pascoini, A. L., Komotar, R. J., & Ivan, M. E. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03778-8 · Cited by 19
Pieri, V., Gallotti, A. L., Drago, D., Cominelli, M., Pagano, I., Conti, V., Valtorta, S., Coliva, A., Lago, S., Michelatti, D., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0677 · Cited by 19
Bachal, K., Yadav, S., Gandhi, P. S., & Majumder, A. (2022) · Lab on a Chip · doi:10.1039/d2lc00879c · Cited by 19
Boholamide A, an APD-Class, Hypoxia-Selective Cyclodepsipeptide
Torres, J. P., Lin, Z., Fenton, D. S., Leavitt, L. U., Niu, C., Lam, P., Robes, J. M. D., Peterson, R. T., Concepción, G. P., Haygood, M. G., et al. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00038 · Cited by 18
Brain tumor vessels—a barrier for drug delivery
Hempel, C., Johnsen, K. B., Kostrikov, S., Hamerlik, P., & Andresen, T. L. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09877-8 · Cited by 18
Paraiso, W. K. D., García-Chica, J., Ariza, X., Zagmutt, S., Fukushima, S., García, J., Mochida, Y., Serra, D., Herrero, L., Kinoh, H., et al. (2021) · Biomaterials Science · doi:10.1039/d1bm00689d · Cited by 18
Schnöller, L. E., Piehlmaier, D., Weber, P., Brix, N., Fleischmann, D. F., Nieto, A. E., Selmansberger, M., Heider, T., Heß, J., Niyazi, M., et al. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02241-4 · Cited by 19
Towards an advanced cell-based in vitro glioma model system
Mikhailova, V., Gulaia, V. S., Tiasto, V., Александрович, Р. С., Yatsunskaya, M., & Kagansky, A. (2018) · Global Medical Genetics · doi:10.3934/genet.2018.2.91 · Cited by 18
Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4
Pin, G., Yu, Y., Tian, Z., Lin, Y., Qiu, Y., Yao, W., & Zhang, L. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4498 · Cited by 18
Single-cell tracking reveals super-spreading brain cancer cells with high persistence
Nousi, A., Søgaard, M. T., Audoin, M., & Jauffred, L. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101120 · Cited by 19
Phenocopying Glioblastoma: A Review
Oraiopoulou, M., Tzamali, E., Papamatheakis, J. D., & Sakkalis, V. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2021.3111744 · Cited by 17
Song, T., Yao, M., Yang, Y., Liu, Z., Zhang, L., & Li, W. (2023) · Phenomics · doi:10.1007/s43657-023-00103-3 · Cited by 17
TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness
Guo, S., Ramar, V., Guo, A. A., Saafir, T. B., Akpobiyeri, H., Hudson, B., Li, J., & Liu, M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04921-6 · Cited by 17
Resende, F. F. B., Titze-de-Almeida, S. S., & Titze‐de‐Almeida, R. (2018) · Oncology Letters · doi:10.3892/ol.2018.7917 · Cited by 17
Nano hydroxyapatite induces glioma cell apoptosis by suppressing NF‑κB signaling pathway
Guo, G., Tian, A., Lan, X., Fu, C., Yan, Z., & Wang, C. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7418 · Cited by 17
Fishing for Contact: Modeling Perivascular Glioma Invasion in the Zebrafish Brain
Umans, R. A., ten Kate, M., Pollock, C., & Sontheimer, H. W. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00129 · Cited by 17
AQP8 promotes glioma proliferation and growth, possibly through the ROS/PTEN/AKT signaling pathway
Zhang, H., Huajun, S., Zhen, G., Yu, X., Liu, Q., Ziling, C., Zihao, S., Xia, Q., & Zhu, S. (2023) · BMC Cancer · doi:10.1186/s12885-023-11025-8 · Cited by 17
Wang, Y., Song, W., Kan, P., Huang, C., Ma, Z., Wu, Q., Yao, X., & Zhang, B. (2018) · Oncology Reports · doi:10.3892/or.2018.6691 · Cited by 17
Stabley, D. L., Holbrook, J., Harris, A. W., Swoboda, K. J., Crawford, T. O., Sol‐Church, K., & Butchbach, M. E. R. (2017) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.02.002 · Cited by 18
Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining
Mu, F.-G., Liu, T., Zheng, H., Xie, X., Lei, T., He, X., Du, S., Tong, R., & Wang, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6756 · Cited by 16
Metadata
- Authors
- Allen, M., Bjerke, M., Edlund, H., Nelander, S., & Westermark, B.
- Affiliations
- Uppsala University (SE)
- Corresponding author
- Westermark, Bengt
- Venue
- Science Translational Medicine
- Published
- 2016-08-31
- Volume
- 8
- Issue
- 354
- Pages
- 354re3-354re3
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2509121458
- Cited by
- 466
- References
- 15
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 43 · 2023: 36 · 2022: 49 · 2021: 41 · 2020: 59 · 2019: 51 · 2018: 84 · 2017: 37 · 2016: 5
- FWCI
- 42.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Swedish Cancer Society
- Swedish Crime Victim Compensation and Support Authority
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- glioma cell lines, glioblastoma, tumor origin, genetic profiling, gene expression profiling, cell line misidentification, translational oncology
- MeSH terms
- Brain Neoplasms, DNA, Mitochondrial, DNA, Neoplasm, Glioblastoma, Glioma, Humans, DNA Fingerprinting, Microsatellite Repeats, Cell Culture Techniques, Gene Expression Profiling, Cell Line, Tumor, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review